Neighborhood matters: Altered lipid metabolism in APOE4 microglia causes problems for neurons

Jessica E Young1, Suman Jayadev2

  • 1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.

Cell Stem Cell
|August 5, 2022
PubMed

Insights

Human microglia with the Alzheimer's disease risk allele APOE4 show altered lipid metabolism and activation. This impacts neuronal network activity, suggesting a new therapeutic target for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Microglia are the brain's resident immune cells and play a critical role in AD pathogenesis.
  • The apolipoprotein E (APOE) gene is a major genetic risk factor for late-onset AD, with the APOE4 allele conferring the highest risk.

Purpose of the Study:

  • To investigate the functional consequences of the APOE4 allele on human microglia.
  • To explore the impact of APOE4-associated microglial changes on neuronal network activity.
  • To identify novel therapeutic targets for Alzheimer's disease.

Main Methods:

  • Utilized human microglia carrying the APOE4 allele.
  • Analyzed lipid metabolism and cellular activation states in these microglia.
  • Assessed the effects of altered microglia on neuronal network function.

Main Results:

  • Human microglia with the APOE4 allele exhibit dysregulated lipid metabolism.
  • APOE4-carrying microglia display altered cellular activation patterns.
  • These microglial alterations lead to dampened neuronal network activity.

Conclusions:

  • The APOE4 allele significantly impacts human microglial function, particularly lipid metabolism and activation.
  • Altered microglia contribute to reduced neuronal network activity, a potential mechanism in Alzheimer's disease.
  • Targeting microglial lipid metabolism and activation presents a promising therapeutic strategy for Alzheimer's disease.